N-(tert-Butoxycarbonyl)-2,2'-(ethylenedioxy)diethylamine>97.0%(HPLC)1g

4-[(2-methylhydrazin-1-yl)methyl]-N-(propan-2-yl)benzamide hydrochloride, 97.0%, 100mg

6-Bromo-2H-benzo[e][1,3]oxazine-2,4(3H)-dione, 98+%, 250mg

2-((((Benzyloxy)carbonyl)amino)methyl)thiazole-4-carboxylic acid, 98%, 1g

2-Amino-5-bromopyridine, 99.00%, 250g

1,1-Dimethyl-3-phenylurea, 95.0%, 5g

Gluconic acid sodium salt, min. 99%, for synthesis, 1 kg, plastic packaging.

Methyl 1-benzylpiperidine-4-carboxylate, 97.0%, 10g

trans-2-(4-Aminocyclohexyl)acetic acid hydrochloride, 95.0%, 1g

3-Bromo-2-fluoro-6-(trifluormethyl)benzaldehyde, 95.0%, 250mg

Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride, 95.0%, 100mg

3-Methyl-1-[3-(trifluoromethyl)phenyl]-1H-pyrazol-5-amine, 1g

Ethyl 3-Oxo-3-(p-tolyl)propionate>95.0%(GC)(T)5g